biopro logo

TEAM

biopro team has been built in the IE Business School and has an extensive experience in the Biomedical Research field.

  • Dr. Ignacio Pérez de Castro, (CSO and Administration board member), senior Cancer Research Scientist with more than 22 years of experience in Cancer Research groups in Spain and USA. As CSO, he will coordinate all the scientific activities of BioPro.
  • Dr. Carmen Galán, a multidisciplinary scientist with more than 13 years of experience in basic research and with experience in developing marketing activities for international research institutions will collaborate as creative in the activities related with the gain of visibility of the Cancer Institutes.
  • Pawel Mikulski, is an enthusiastic and creative young scientist, currently obtaining his PhD in Genetics on University of Duesseldorf, who will act as an Administrative Board member paying special attention to the Financial tasks of BioPro.
  • Lilit Manukyan, is a Research Project Manager possessing strong understanding of research and innovation programs, with more than 8 years of experience in Scientific Project Management. She will supervise the designing, implementation and follow up of the research projects.

Scientific Board. An international panel of excellent cancer researchers will be in charge of the evaluation of the scientific projects to be included in biopro portfolio.

  • Dr. Mariano Barbacid. He is one of the most prestigious Spaniard molecular oncologists. His work, National Cancer Institute (NCI), Bethesda, Maryland, USA, led to the isolation of the first human cancer gene, H-RAS, in the spring of 1982 and to the identification of the first mutation associated with the development of human cancer. In 1998, he created and directed the Spanish National Cancer Research Center (CNIO). The relevance of his work has been recognized by many domestic and international awards, including the Young Investigator Award of the American Association of Cancer Research (USA, 1986), the Steiner Prize (Switzerland, 1988), the Ipsen Prize (France, 1994), the Brupbaher Cancer Research Prize (Switzerland, 2005) and the Medal of Honor of the International Agency for Cancer Research (WHO) (Lyon 2007). He holds Honorary Degrees (Doctor Honoris Causa) from the Universidad Internacional Menendez y Pelayo (1995) and the University of Cantabria (2011). He is a Member of EMBO (1996) and the European Academy of Cancer Sciences (2009). In 2012, he was elected a Foreign Member of the National Academy of Sciences, USA. To date, Dr. Barbacid has authored 267 publications and has Hirsch "h" factor of 96.
  • Angel Pellicer. He is a Full Professor at the Department of Pathology of New York University. Dr. Pellicer did a residency in Internal Medicine at Central Army Hospital. He was a Postdoctoral fellow at the Institute of Cancer Research, Columbia University, Residency. He has focused his career in the study of the mechanisms of oncogene activation, tumor suppressor gene inactivation and the function that these genes have in malignant transformation and normal cellular processes. He has published more than 140 publications on the field.
  • Lisardo Boscá. He is a CSIC Research Professor at the Institute of Biomedical Investigations Alberto Sols. He began his studies under the direction of Professor Alberto Sols. He has worked also at the Faculty of Medicine of the University of Louvain in Brussels, at Oxford, London and Ottawa. He has focussed on the study of the pathophysiology of inflammatory processes, investigating their contribution to processes as diverse as liver regeneration, septic shock and myocarditis. He has authored over 200 original research articles in international journals of wide distribution in the field of Biochemistry, Molecular Biology and Immunology. He is a member of the Royal Academy of Pharmacy and several international scientific societies. He has been Vice-Director of the Spanish National Health Institute.
  • Elías Campo.He is a Doctor of Medicine and Surgery, Spanish pathologist and researcher specializing in lymphoid malignancies. He is Head of Section of the Department of Pathology and Clinical Hospital Provincial de Barcelona and clinical director of the Biomedical Diagnostic Center (CDB) in the same hospital. He is also responsible for the team of functional human experimental research in oncomorphology of IDIBAPS. Together with Dr. Carlos López Otín, act as scientific directors of the draft genome sequencing of lymphatic leukemia chronic.